01 Industry overview
The prosthetics industry at a glance
The global prosthetics and orthotics market is estimated at $7.1 billion in 2026, with demand supported by population aging, diabetes-related amputations, trauma, and technology adoption.
- $7.1B[3]
- Global market estimate, 2026
- 4.2%[3]
- Forecast CAGR, 2026–2033
- 36.8%[3]
- North America share, 2025
- 9,500[5]
- U.S. jobs, 2025
- Market size
- The global prosthetics and orthotics market was valued at $6.8 billion in 2025 and is estimated at $7.1 billion in 2026. The figures include prosthetic and orthotic products and related market segments.[3]
- Forecast & CAGR
- The market is forecast to reach $9.5 billion by 2033, representing a 4.2% compound annual growth rate from 2026 to 2033. A separate 2026 estimate places the market at $8.23 billion in 2026 and forecasts $11.50 billion by 2032 at a 5.62% CAGR, reflecting differences in market scope and methodology.[3][1]
- Market share & regions
- North America held the largest regional share of the global prosthetics and orthotics market at 36.8% in 2025. In the United States, the country represented 89.6% of the North American market in 2025, according to one market estimate.[3][17]
- Segmentation
- Lower-limb products represented 63.4% of the U.S. prosthetics and orthotics market in 2025, while prosthetic devices overall accounted for 51.8%. Common segmentation categories include lower- and upper-limb products, spinal products, and other devices.[17]
- Key players & concentration
- Publicly available sources do not provide a reliable global concentration ratio for prosthetics manufacturers or providers. Ottobock reported nearly 9,300 employees and approximately 420 patient-care clinics worldwide in 2026, illustrating the scale of a major integrated participant but not the company’s global market share.[18]
- Pricing
- For 2025, CMS reported average Medicare fee-schedule amounts of $3,088.30 for HCPCS codes L5783 and L7406 associated with a prosthesis artificial-leg payment determination. Medicare generally pays 80% of the lower of the supplier’s charge or the fee-schedule amount, with the beneficiary responsible for 20% plus any unmet Part B deductible.[19]
- Trends, drivers & challenges
- The U.S. Bureau of Labor Statistics identifies population aging, obesity, diabetes, and trauma as demand drivers and projects 13% employment growth for orthotists and prosthetists from 2025 to 2035. The industry is also moving toward microprocessor-controlled knees, myoelectric upper-limb systems, digital fabrication, and other sensor-based technologies, while reimbursement and access remain constraints.[5][17]
- Consumer behavior & competition
- In the United States, 35% of orthotists and prosthetists worked in ambulatory healthcare services in 2025, 25% in medical equipment and supplies manufacturing, and 12% in health and personal-care retail. Competition therefore spans clinical providers, component manufacturers, fabrication businesses, and integrated patient-care networks.[5]
- M&A
- M&A and portfolio restructuring continued in 2026: Allard USA sold its SmartFAB subsidiary to Bionic Prosthetics & Orthotics on February 25, 2026, renaming the business OneSource – Integrated O&P Solutions. The transaction was described as a divestiture intended to focus Allard’s resources on its core orthotics and prosthetics businesses.[20]
- Regulation
- In the United States, prosthetic components are regulated as medical devices under FDA product classifications; external limb prosthetic components can fall under Class I, regulation 21 CFR 890.3420, while some powered upper-extremity prostheses are Class II under 21 CFR 890.3450. Medicare coverage also requires that lower-limb prostheses meet benefit-category, reasonable-and-necessary, and other statutory requirements.[14][19]
- Latest news
- In September 2026, Ottobock announced a settlement of its intellectual-property litigation with Cranial Technologies and said it would remove the MyCRO Band cranial helmet from its U.S. portfolio. The company reported nearly 9,300 employees and about 420 patient-care clinics worldwide in the same announcement.[18]
02 Ranking
Top 10 Companies in the Prosthetics Industry
The leading companies in the prosthetics industry, ranked on market impact, performance, momentum, innovation and brand popularity.
Updated November 20, 2026 · Next review December 20, 2026
Eqwal Group stands out for custom prosthetic devices fitted through a multinational O&P network because it uses that network model for orthoprosthetic patient care, while Ottobock focuses on prosthetic limbs, components and bionics since it reported revenue growth of 4.7%.
Ranked by Overall score · How we score ↓
Editor's top 3 picks
Where to start, by need.
#1 Overall · Leader in orthoprosthetic patient care
Eqwal Group
FR
Ranked #1 · 9.1 · Orthoprosthetic patient care
Why we picked it: It works across orthoprosthetic patient care and custom prosthetic devices through a multinational O&P network.
Leader in lower-limb prosthetics
Ottobock
DE
Ranked #2 · 9.0 · Lower-limb prosthetics
Why we picked it: It markets prosthetic limbs, components, and bionics and reported revenue growth of 4.7%.
Leader in digital O&P
Proteor
FR
Ranked #3 · 8.8 · Digital O&P
Why we picked it: It focuses on lower-limb prosthetic components and digital O&P for external prostheses.
Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.
Full ranking
| # | Company | Overall ↓ | Impact | Performance | Momentum | Innovation | Company snapshot |
|---|---|---|---|---|---|---|---|
| 1 | Eqwal Group Orthoprosthetic patient care · FR | 9.1 | 9.1 | 9.9 | 9.9 | 7.0 | |
Company snapshot · Eqwal Group · Data as of November 20, 2026 Eqwal designs, manufactures and fits custom prosthetic devices through a multinational O&P network.[21]
| |||||||
| 2 | Ottobock Lower-limb prosthetics · DE | 9.0 | 9.9 | 7.0 | 8.9 | 9.9 | |
Company snapshot · Ottobock · Data as of November 20, 2026 Ottobock describes itself as the global market leader in prosthetics.[8]
| |||||||
| 3 | Proteor Digital O&P · FR | 8.8 | 8.7 | 8.4 | 9.2 | 8.9 | |
Company snapshot · Proteor · Data as of November 20, 2026 Proteor is a leading designer and manufacturer of external prostheses, mainly for lower limbs.[22]
| |||||||
| 4 | Hanger Orthoprosthetic patient care · US | 8.5 | 9.3 | 8.4 | 8.5 | 7.0 | |
Company snapshot · Hanger · Data as of November 20, 2026 Hanger operates the largest U.S. field organization dedicated solely to O&P patient care.[23]
| |||||||
| 5 | Blatchford Lower-limb prosthetics · GB | 8.2 | 8.9 | 7.4 | 8.2 | 8.0 | |
Company snapshot · Blatchford · Data as of November 20, 2026 Blatchford manufactures advanced prosthetic legs, knees and ankles for global markets.[24]
| |||||||
| 6 | Össur Prosthetics, orthotics and bracing globally · IS | 8.2 | 9.5 | 7.6 | 7.0 | 8.0 | |
Company snapshot · Össur · Data as of November 20, 2026 Leading global manufacturer of non-invasive orthopaedic prosthetics and bracing.[25]
| |||||||
| 7 | Fillauer Upper and lower limb prosthetics, US · US | 8.2 | 7.9 | 8.4 | 8.5 | 8.0 | |
Company snapshot · Fillauer · Data as of November 20, 2026 US manufacturer of prosthetic components for upper and lower limbs.[26]
| |||||||
| 8 | Aether Biomedical Upper-limb bionic prostheses · PL | 8.1 | 7.0 | 8.4 | 9.6 | 8.0 | |
Company snapshot · Aether Biomedical · Data as of November 20, 2026 Aether Biomedical develops and commercializes the Zeus multi-articulating bionic hand.[27]
| |||||||
| 9 | WillowWood Prosthetic liners, feet, knees and sockets · US | 7.8 | 7.8 | 7.6 | 8.5 | 7.0 | |
Company snapshot · WillowWood · Data as of November 20, 2026 WillowWood manufactures prosthetic liners, feet, knees and other technologies for amputees.[28]
| |||||||
| 10 | College Park Industries Lower-limb prosthetic feet and ankles, US · US | 7.5 | 7.9 | 7.6 | 7.0 | 7.0 | |
Company snapshot · College Park Industries · Data as of November 20, 2026 Specialist manufacturer of prosthetic feet and lower-limb components.[29]
| |||||||
How we score
- Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
- Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
- Momentum (20%): growth trajectory and future potential.
- Innovation (15%): R&D intensity and how technologically advanced the company is.
Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.
Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.
Cadence Recalculated when new figures are published; next review December 20, 2026.
Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.
Cite this ranking
APA
Thomas Lindqvist. (2026, February 13). Top 10 companies in the prosthetics industry. In Prosthetics Industry Statistics. Gitnux. https://gitnux.org/prosthetics-industry-statistics/#top-companies
India orthopaedics and prosthetics market segment value, 2020
Other artificial body parts holds the largest share at $106.7M.
03 Trends & forecasts
Top 10 Prosthetics Industry Trends & Forecasts 2027
What is changing in the prosthetics industry, with the evidence behind each trend and a forecast for 2027.
Forecasts were generated by an AI model from the cited evidence. They are estimates, not guarantees.
01Market growth remains moderate
Medium confidenceThe global prosthetics and orthotics market was estimated at $7.1 billion in 2026, up from $6.8 billion in 2025, and is projected to reach $9.5 billion by 2033 at a 4.2% CAGR. Estimates vary by market scope: another 2026 study places the market at $7.60 billion and forecasts $9.54 billion by 2033.[3][30]
Forecast 2027: In 2027, industry revenue should expand at roughly 4%–5% globally, with growth driven more by replacement demand, premium components and clinical services than by a sharp increase in procedure volumes.
02Aging populations expand demand
High confidenceThe United Nations projects that the global population aged 65 or older will increase from about 771 million in 2022 to 994 million by 2030. The U.S. Bureau of Labor Statistics identifies population aging and age-related conditions as drivers of demand for orthotic and prosthetic care.[31][5]
Forecast 2027: In 2027, providers will continue to see rising demand for mobility devices, fall-related rehabilitation and replacement limbs, particularly in higher-income countries with rapidly aging populations.
03Diabetes sustains amputation demand
High confidenceThe World Health Organization reports that 830 million people were living with diabetes in 2022, compared with 200 million in 1990, and states that diabetes can cause lower-limb amputation. Diabetes prevalence among adults rose from 7% in 1990 to 14% in 2022.[32]
Forecast 2027: In 2027, diabetes-related complications will remain a structural source of lower-limb prosthetic demand, especially in low- and middle-income countries where treatment coverage remains limited.
04Lower-limb products retain leadership
Medium confidenceLower-limb products represented 63.4% of the U.S. prosthetics and orthotics market in 2025. The segment includes feet, ankles, knees, hips and related mobility devices, which generally require load-bearing performance and frequent clinical fitting.[17]
Forecast 2027: In 2027, lower-limb devices should remain the largest product category, with premium knees, feet, liners and suspension systems accounting for a disproportionate share of value growth.
05North America remains the largest region
Medium confidenceNorth America accounted for 36.8% of global prosthetics and orthotics market revenue in 2025. The region benefits from established healthcare infrastructure, reimbursement systems and the presence of major manufacturers and clinical networks.[3]
Forecast 2027: North America is likely to remain the largest regional market in 2027, although Asia-Pacific should continue growing faster from a smaller base.
06Asia-Pacific outpaces mature markets
Medium confidenceMarket research identifies Asia-Pacific as the fastest-growing regional market and projects it to reach $2,396.7 million by 2033. Growth is associated with expanding healthcare infrastructure, rising injury burdens and increasing access to mobility technologies.[3]
Forecast 2027: In 2027, manufacturers and central fabricators will likely increase distribution, training and lower-cost product offerings in Asia-Pacific, while premium adoption remains concentrated in urban healthcare systems.
07Digital fabrication becomes standard
Medium confidenceOttobock states that digitalization is being used to improve patient care, production accuracy, error reduction and resource efficiency. Its business includes digital orthotics and prosthetics solutions alongside conventional products and patient care.[8]
Forecast 2027: By 2027, more clinics and fabrication businesses should combine digital shape capture, computer-aided design and digitally controlled manufacturing, reducing turnaround times for selected custom devices.
08Bionic components gain share
High confidenceOttobock lists microprocessor-controlled knees, app-connected C-Leg systems and multi-articulating bebionic hands among its core technologies. Grand View Research also identifies bionics, 3D printing and lightweight materials as adoption drivers.[8][3]
Forecast 2027: In 2027, microprocessor knees, powered feet and myoelectric upper-limb systems should continue taking share of premium spending, although reimbursement and affordability will constrain broad-based adoption.
09Clinical workforce capacity tightens
High confidenceThe U.S. Bureau of Labor Statistics counted about 9,500 orthotist and prosthetist jobs in 2025 and projects employment to reach 10,700 by 2035, a 13% increase. It also projects about 700 openings annually over the decade, partly because of replacement needs.[5]
Forecast 2027: In 2027, labor availability will remain a constraint in the United States and other mature markets, encouraging central fabrication, technician training, workflow automation and larger multi-site providers.
10Reimbursement keeps premium prices selective
High confidenceCMS reported average 2025 Medicare fee-schedule amounts of $3,088.30 for HCPCS codes L5783 and L7406 associated with an artificial-leg payment determination. CMS also notes that fee-schedule amounts are updated annually and vary by payment rules and locality.[19]
Forecast 2027: In 2027, reimbursement updates should support incremental price increases for covered devices, but premium powered and sensor-based components will continue to face coverage, documentation and patient-cost barriers.
04 Statistics
Market Intelligence
Market sizing anchors the year: the global prosthetics-and-orthotics market is estimated at $7.1 billion in 2026 and projected to reach $9.5 billion by 2033.
Market size, volume and shipments in the prosthetics industry
- $7.84 billion was the estimated global 2025 prosthetics-and-orthotics market size, covering the market by product, technology, application and end user, according to 360iResearch.[1]
- $8.8 billion was the global 2025 prosthetics-and-orthotics market size, covering products and services classified by type, according to The Business Research Company.[2]
- $6.8 billion was the global 2025 prosthetics-and-orthotics market size, covering orthotic and prosthetic devices and related market revenue, according to Grand View Research.[3]
Forecast growth and shipments in the prosthetics industry
- The global prosthetics-and-orthotics market is projected to reach $9.5 billion in 2033 from $7.1 billion in 2026, implying 4.2% CAGR during 2026–2033; the category covers orthotic and prosthetic products.[3]
- The global prosthetics-and-orthotics market is projected to reach $11.50 billion in 2032 from an estimated $8.23 billion in 2026, implying 5.62% CAGR during 2026–2032.[1]
- The global prosthetics-and-orthotics market is projected to reach $11.81 billion in 2030 from $9.37 billion in 2026, implying 5.9% CAGR during 2026–2030; the category covers products and services.[2]
Company counts and size structure in the prosthetics industry
- 88,728 employees worked in U.S. NAICS 339113, a parent category including prosthetic appliances, according to OSHA’s 2024 industry table.[4]
- 1,786 U.S. establishments operated in NAICS 339113, a parent manufacturing category including prosthetic appliances, according to OSHA’s 2024 industry table.[4]
- 1,622 U.S. firms operated in NAICS 339113, Surgical Appliance and Supplies Manufacturing, a parent category including prosthetic appliances, in OSHA’s 2024 industry table.[4]
05 Statistics
People & Workforce
U.S. workforce numbers show capacity pressure: orthotists and prosthetists were 9,500 jobs in 2025, projected to rise 13% to 10,700 by 2035.
Employment and hiring in the prosthetics industry
- 103.0 thousand employees worked in U.S. Surgical Appliance and Supplies Manufacturing (2022 NAICS 339113) in April 2026, down from 106.6 thousand in April 2025.[5]
- Employment of U.S. orthotists and prosthetists is projected to increase 13%, from 9,500 jobs in 2025 to 10,700 in 2035.[5]
- 9,500 orthotists and prosthetists were employed in the United States in 2025; 25% worked in medical equipment and supplies manufacturing.[5]
Wages and labour costs in the prosthetics industry
- The median annual wage for U.S. orthotists and prosthetists was $81,110 in May 2025; the median was $83,370 in medical equipment and supplies manufacturing.[5]
- Average weekly earnings in U.S. Surgical Appliance and Supplies Manufacturing were $1,379.58 in September 2026, up from $1,268.71 in October 2025.[5]
- Average hourly earnings in U.S. Surgical Appliance and Supplies Manufacturing were $34.75 in September 2026, up from $31.56 in October 2025.[5]
Workplace safety in the prosthetics industry
- U.S. Surgical Appliance and Supplies Manufacturing recorded 1.8 nonfatal occupational injuries and illnesses per 100 full-time workers in 2024.[5]
- U.S. Surgical Appliance and Supplies Manufacturing recorded 0.9 cases involving days away from work per 100 full-time workers in 2024.[5]
- U.S. Surgical Appliance and Supplies Manufacturing recorded 0.4 cases involving job transfer or restriction per 100 full-time workers in 2024.[5]
- U.S. Surgical Appliance and Supplies Manufacturing recorded 0.5 cases involving days away from work, job transfer or restriction per 100 full-time workers in 2024.[5]
06 Statistics
Customers & Channel
Channel context is visible in fitting outcomes and replacement patterns, including a 94% functional rate for Swedish prostheses fitted during 2019–2024.
Demand by end use for prosthetics
- 94% of 4,887 Swedish prostheses fitted during 2019–2024 were functional, 5% additional, and less than 1% cosmetic; this is a volume split by prosthesis use class.[6]
- 43% of 4,599 Swedish prostheses fitted during 2019–2024 were first prostheses at the current amputation level, while 57% were replacements; this is a volume split by fitting type.[6]
- 54% of Swedish prosthetic fittings during 2019–2024 involved socket-only replacement and 13% involved full-prosthesis replacement; this is a volume split by replacement type.[6]
- 88% of 142 advanced artificial limbs supplied by a state-sponsored Indian rehabilitation institute were lower-limb prostheses and 12% were upper-limb prostheses; this is a volume split by anatomical application.[7]
07 Statistics
Pricing & Finance
Pricing constraints show up in Medicare fee-schedule amounts, with $3,088.30 for HCPCS codes L5783 and L7406 tied to an artificial-leg payment determination in 2025.
Margins and profitability in the prosthetics industry
- 25.7% was Ottobock’s underlying EBITDA margin in the Americas in 2025, covering its broader Products & Components business that includes prosthetics and related orthotic products.[8]
- 63% was Embla Medical’s gross-profit margin in the first half of 2026 for Prosthetics & Neuro Orthotics, compared with 63% in the first half of 2025.[9]
- 25.9% was Ottobock’s underlying EBITDA margin in EMEA in 2025, covering its broader Products & Components business that includes prosthetics and related orthotic products.[8]
08 Statistics
Trade & Footprint
Cross-border scale appears in trade: HS 902139 artificial body parts included 2.9 thousand tonnes imported worldwide in 2025 with a unit value of $964 thousand per tonne.
Imports and exports of prosthetics
- 2.9 thousand tonnes of HS 902139 artificial body parts were imported worldwide in 2025, with a unit value of $964 thousand per tonne; HS 902139 excludes artificial teeth, dental fittings and artificial joints.[10]
- $13.715 billion was exported and $20.914 billion imported in 2023 for APEC orthotics and prosthetics, covering HS 902110, 902131 and 902139; these are trade values in U.S. dollars.[11]
- $17.6 billion of HS 902139 artificial body parts were exported worldwide in 2025; the code includes products broader than prosthetic limbs and includes re-exports.[12]
- 35.6% of APEC assistive-product exports in 2023 were orthotics and prosthetics under HS 902110, 902131 and 902139, measured by export value.[11]
09 Statistics
Regulation & Risk
Regulatory scope varies by device and power features, including Class I external-limb prosthetic components under 21 CFR 890.3420 and some powered upper-extremity prostheses as Class II under 21 CFR 890.3450.
Regulations and compliance for prosthetics
- Class III applies to total or partial joint replacements under Rule 8 of Regulation (EU) 2017/745, subject to the stated exceptions for ancillary components such as screws, wedges, plates and instruments.[13]
- 206 FDA product-classification results matched “prosthesis” in the U.S. device classification database, covering prosthesis-related product codes and device classes.[14]
- Class I and 510(k)-exempt status applies to FDA product code ISP, an external-limb prosthetic component; establishments must still register, and the classification page was updated October 5, 2026.[14]
Recalls and safety notices for prosthetics
- 1 recall was listed for FDA product code IQZ, powered external hand prostheses, involving Kinova Inc. and posted October 11, 2024.[14]
- 2 medical-device report events were recorded in 2024 for FDA product code IQZ, powered external hand prostheses; the FDA database also records 2 reports in 2026.[14]
- 12 recalls were listed for FDA product code MBH, semi-constrained uncemented porous-coated knee prostheses, including recalls posted through September 16, 2026.[14]
- 3 complaints involving 4 devices triggered the Exactech Vantage ankle-prosthesis recall, initiated November 21, 2023 and posted January 18, 2024.[14]
10 Statistics
Sustainability
Reuse and recycling show measurable volume, including 13,000+ surplus and little-used prosthetic components redistributed globally from 2018 to 2025.
Waste and circularity in the prosthetics industry
- Recovery and dismantling yielded 39 unused prostheses and 190 potentially reusable components in the Eastern Cape public healthcare sector.[15]
- 3,640 prosthetic components were shipped globally in 2024 through Penta Medical Recycling’s reuse programme.[16]
- 13,000+ surplus and little-used prosthetic components were redistributed globally from 2018 to 2025 by Penta Medical Recycling, including components recovered for reuse rather than discarded.[16]
Key questions about the Prosthetics Industry
What is the 2026 market size for prosthetics and orthotics?
How fast does the market grow from 2026 onward?
Which companies lead the prosthetics industry?
What technology shifts are shaping prosthetics demand and delivery?
How is the U.S. market split by product area?
What income and employment signals appear in U.S. workforce statistics?
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Thomas Lindqvist. (2026, February 13). Prosthetics Industry Statistics. Gitnux. https://gitnux.org/prosthetics-industry-statistics
Thomas Lindqvist. "Prosthetics Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/prosthetics-industry-statistics.
Thomas Lindqvist. 2026. "Prosthetics Industry Statistics." Gitnux. https://gitnux.org/prosthetics-industry-statistics.
Sources & references
32 sources cited across this report
360iresearch.com
researchandmarkets.com
grandviewresearch.com
osha.gov
bls.gov
- rcsyd.se
journals.sagepub.com
corporate.ottobock.com
docs.publicnow.com
trademap.org
apec.org
hscodeatlas.com
eur-lex.europa.eu
accessdata.fda.gov
pmc.ncbi.nlm.nih.gov
- zeroproject.org
emergenresearch.com
ottobock.com
cms.gov
- allardusa.com
- eqwalgroup.com
- fr.proteor.com
corporate.hanger.com
- blatchfordmobility.com
ossur.com
- fillauer.com
- aetherbiomedical.com
- willowwood.com
- college-park.com
coherentmarketinsights.com
digitallibrary.un.org
who.int
